Pharmaceuticals
EzriCare, Delsam Artificial Tears Contaminated with Bacteria Class Action
How would you feel if you discovered that in using certain eyedrops, you were dropping bacteria into your eyes? The complaint for this class action brings suit against EzriCare, LLC, EzriRx, LLC, Delsam Pharma, LLC, Global Pharma Healthcare Private, Ltd., and Aru Pharma, Inc., alleging that the two products, EzriCare Artificial Tears and Delsam Pharma Read more
Namenda Antitrust Indirect Payors Settlement
The defendants in this Brand Settlement of an antitrust lawsuit include Actavis, plc, Forest Laboratories, LLC, (makers of Namenda), Merz GmbH, Merz Pharmaceuticals GmbH, and Merz Pharma GmbH & Co. KgaA (the patent holders for Namenda). The complaint alleged that these Brand Defendants, along with the Generic Defendants, conspired in a monopolization scheme to keep Read more
Chantix Stop-Smoking Drug Adulterated with Nitrosamines Class Action
Pfizer, Inc. makes the varenicline-containing drug (VCD) Chantix, which is used to help smokers stop smoking. The complaint for this class action alleges that Chantix has recently been adulterated or misbranded because it has been contaminated with a probable carcinogen called N-nitroso-varenicline. Read more
Pfizer Chantix Adulterated with N-Nitroso-Varenicline Class Action
One of Pfizer, Inc.’s most popular products is the varenicline-containing drug (VCD) Chantix. Chantix is designed to help people stop smoking, and, unlike many other products for this use, it does not contain nicotine. However, the complaint for this class action alleges that the drugs have recently been contaminated with N-nitroso-varenicline, and possibly other substances Read more
Bristol-Myers Squibb HIV cART Drugs Antitrust Direct Purchaser Partial Settlement
This is a partial settlement of an antitrust class action against Bristol-Myers Squibb Company, ER Squibb & Sons, LLC, and others. The complaints alleged that the companies violated antitrust laws by conspiring to extend patent protection for antiretroviral drugs for treating human immunodeficiency virus (HIV cART drugs) by engaging in anticompetitive conduct and restraining competition, Read more
Ranbaxy TPP Generic Nexium, Diovan, and Valcyte Settlement
Sun Pharmaceutical Industries, Ltd. and Ranbaxy, Inc. are settling combined class actions alleging generic drug manufacturer Ranbaxy made misrepresentations about both the conditions in its plants and the results of analyses on the integrity of data at the plants. This allowed it to obtain “tentative approval” from the Food and Drug Administration (FDA) and a Read more
Avanir Encouraged Nuedexta Use for Off-Label Purposes Class Action
When drugs are approved by the Food and Drug Administration (FDA), they are approved for specific uses, to treat specific diseases or problems. The complaint for this class action brings suit against Avanir Pharmaceuticals, Inc., which it claims attempted to market a drug called Nuedexta for other than its original uses, including, it claims, by Read more
Pfizer Chantix Contaminated with NDMA Class Action
Pfizer makes the drug Chantix to help people stop smoking. The complaint refers to Chantix as a VCD, or varenicline-containing drug. But the complaint for this class action alleges that the company has been putting out adulterated or misbranded Chantix that has been contaminated with “a probable human carcinogen known as n-nitroso-varenicline.” The complaint alleges Read more
Geron Conceals Study Results, Sells Inflated Stock Class Action
Geron Corporation, a biopharmaceutical company, had just one drug in its pipeline, imetelstat. The complaint for this class action alleges that a Phase 2 clinical trial for the drug produced disappointing results. Despite this, according to the complaint, company insiders sold a large amount of stock without disclosing the results of the trial. This class Read more
Sacklers, Others Cost Pennsylvania Billions via Opioids Class Action
This class action brings suit against seventeen individuals, seven bearing the last or middle name “Sackler,” each of whom, the complaint alleges, has played a part in spreading opioid addiction in Pennsylvania. The complaint charges that they “have gained extreme monetary wealth and caused extreme financial harm to the addicted and their families.” Read more
